High-net-worth individuals (HNIs) such as Ashish Rameshchandra Kacholia and Artian Investments, a UK-based investment banking firm, invested equity finance of around Rs 225 crore (nearly $27 million) to the biopharmaceutical startup PlasmaGen Biosciences.